Category: Finance
Another Goulamina-style monster? First Lithium’s maiden resource is just around the corner
More thick, high grade lithium hits reported from First Lithium’s Blakala prospect, one of only two Tier 1 priority lithium targets in Mali New drill [more…]
Marmota enters new Golden Moon JV to grow its Gawler Craton gold project in SA
Golden Moon JV created to grow Marmota’s Gawler Craton gold resources Tenements are right near MEU’s flagship Aurora Tank gold discovery Gold prices have [more…]
Manuka’s Taranaki vanadium project hits fast-track
Special Report: Manuka Resources is a major step closer to having the final approvals for the world-class Taranaki vanadium titanomagnetite iron sand resource. Through its [more…]
Top 10 at 10: Who’s digging for fluorite, the lithium killer?
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. [more…]
Market Highlights: Tesla to unveil robotaxi, Morningstar’s Q2 prediction, and 5 ASX small caps to watch today
ASX to gain more ground on Tuesday as Wall Street closed flat Elon Musk revealed Tesla’s robotaxi A look at Morningstar’s Q2 prediction for [more…]
Australian Mines unearths multiple REE-niobium targets in Brazil’s emerging Jequie critical minerals belt
Australian Mines uncovers boulder outcrops and saprolite clay systems at the Jequie project in Brazil The explorer has so far targeted what it views as [more…]
This ASX explorer is looking to drill new pasture inside Brazil’s booming Lithium Valley
A growing list of explorers and advanced developers have swooped into Brazil’s Lithium Valley in the mining friendly state of Minas Gerais, where a strong [more…]
Want a chart that shows good things could be on the cards for copper? OFC you do
Copper inventories are back at dire levels, with the LME holding less than two days of global demand Westpac has ratcheted up its copper forecasts [more…]
MoneyTalks: Brokers name ASX-listed health stocks Percheron and Probiotec as ones to watch
Percheron could double if clinical goes well But Taylor Collison admits that PER is a speculative investment Probiotec meanwhile offers a resilient business model, says [more…]
This is what UBS reckons Ozempic is doing to the big US food stocks
The very busy humans at UBS just grabbed 500 GLP-1 users across the US and chewed the fat over the drug made famous by Novo [more…]